Skip to content

Ketamine infusion therapy in an elderly patient with complex regional pain syndrome and major depression

Parinda Parikh, Jeremy Kays, Zoe Gellert, Shaurya K. Singh, Alisha Arul Alphonse, Himani J Suthar, Aatish D. Bhatta, Arnesh Shukla, Parthiv Pansuriya, Arushi K. Chandra, Mahiya Buddhavarapu, Mina Oza

International Journal of Community Medicine and Public Health August 30, 2025 DOI: 10.18203/2394-6040.ijcmph20252868 (opens in new tab)

Study at a glance

AI-extracted from the abstract
Characteristics Case report Peer reviewed
Sample size 1
Population 86-year-old man with CRPS-related back and leg pain
Intervention Intravenous ketamine infusion
Topics Ketamine Depression Esketamine
Keywords Depression economics Anesthesia
Key findings A single intravenous ketamine infusion led to immediate and substantial improvements in pain, mood, and mobility in an elderly patient with refractory CRPS.

Abstract

Complex regional pain syndrome (CRPS) is a chronic pain disorder that severely affects mobility and quality of life. This case report describes an 86-year-old man who has a long-standing history of CRPS-related back and leg pain. Traditional treatments, including opioids and duloxetine, did not improve his symptoms, and due to religious beliefs restricting specific interventions, standard hospital care was limited. Given the severity of his symptoms and the refractory nature of his condition, an intravenous ketamine infusion was recommended to improve pain and comorbid depressive symptoms. Following one treatment, the patient exhibited immediate and substantial improvements in pain intensity, mood, and mobility. This case accentuates the importance of culturally sensitive, patient-centered care and suggests the role of ketamine in treating CRPS when traditional therapies are ineffective.

Comparable studies

Other case reports and case series on ketamine for depression, most cited first.

Study Year Design Participants
Electroconvulsive Therapy, Ketamine, and Esketamine in a Patient with Major Depressive Disorder and Multiple Comorbidities: A Case Report over 10-year Treatment from Adolescence to Adulthood. A patient with treatment-resistant depression and comorbid generalized anxiety... 2025 Case report n = 1
A longitudinal case series of IM ketamine for patients with severe and enduring eating disorders and comorbid treatment‐resistant depression Patients with enduring eating disorders and treatment-resistant depression 2021 Case series n = 4
Effects of intranasal (S)-ketamine on Veterans with co-morbid treatment-resistant depression and PTSD: A retrospective case series Veterans with co-morbid depression and PTSD 2022 Retrospective case series n = 35
Case report: Intramuscular ketamine or intranasal esketamine as a treatment in four patients with major depressive disorder and comorbid anorexia nervosa Patients with anorexia nervosa and a comorbid depressive disorder treated at a private... 2023 Case report n = 4
Repeated oral esketamine in patients with treatment resistant depression and comorbid posttraumatic stress disorder Patients with treatment-resistant depression and comorbid PTSD 2023 Case series n = 5

Explore topics

By condition and practice